Human Genome Diversity Project

Human Genome Diversity Project
Name	Human Genome Diversity Project
Established	1990s
Field	Human genetics
Founders	Francis Collins, Luigi Luca Cavalli-Sforza, Alan R. Templeton
Location	International

Contents

Human Genome Diversity Project

The Human Genome Diversity Project was a proposed international research initiative in the 1990s to catalog genetic variation among diverse human populations. Conceived to complement efforts such as the Human Genome Project, the initiative aimed to sample indigenous and isolated populations to inform studies in population genetics, anthropology, forensic science, and medical genetics. Proponents included figures from institutions like the National Institutes of Health, the Wellcome Trust, and universities such as Stanford University and University of Oxford; opponents included activists associated with Survival International, Greenpeace, and indigenous organizations such as the International Indian Treaty Council.

Background and objectives

The project originated amid debates following the progress of the Human Genome Project and the publication of work by researchers at University of California, Berkeley, Harvard University, and the Max Planck Institute for Evolutionary Anthropology. Key objectives were to construct a global allele-frequency database, map patterns of human migration linked to archaeological sites like Göbekli Tepe and Çatalhöyük, and test hypotheses advanced by scholars such as Luigi Luca Cavalli-Sforza and Richard Lewontin. Organizers proposed collaborations with laboratories at Cold Spring Harbor Laboratory, Broad Institute, Sanger Centre, and field teams connected to museums like the Smithsonian Institution and the American Museum of Natural History.

Protocols proposed techniques from molecular genetics labs at the University of Cambridge, Massachusetts Institute of Technology, and Yale University. Sampling strategies discussed mitochondrial DNA (mtDNA), Y-chromosome markers, and autosomal single nucleotide polymorphisms (SNPs) using technologies developed at companies like Illumina and institutions including the Whitehead Institute. Fieldwork plans invoked partnerships with anthropologists from University of Chicago, linguists affiliated with Max Planck Institute for Psycholinguistics, and ethnographers associated with University of Toronto. Data storage and sharing proposals referenced practices at the European Bioinformatics Institute, GenBank, and the Human Genome Organisation. Consent procedures drew on precedents from projects at World Health Organization and bioethics frameworks discussed in forums at United Nations Educational, Scientific and Cultural Organization and Council for International Organizations of Medical Sciences.

Although never fully realized as initially proposed, related studies produced contributions through work by researchers at Columbia University, University of Pennsylvania, University of California, Los Angeles, and the Max Planck Institute for Evolutionary Anthropology. Results from comparable population surveys informed reconstructions of migrations tied to events such as the Out of Africa dispersal and the peopling of the Americas, correlating genetic clines with archaeological evidence from sites like Monte Verde and Clovis culture contexts. Studies using SNP panels from groups sampled in projects at Wellcome Trust Sanger Institute and University College London refined models proposed by Allan Wilson and Rebecca Cann and supported work by population geneticists including Svante Pääbo and David Reich. Databases influenced medical genomics research at Mayo Clinic, Johns Hopkins University, and pharmaceutical studies at GlaxoSmithKline and Pfizer.

The initiative spurred debate among scholars and activists at forums hosted by United Nations, World Health Organization, and indigenous bodies such as the Assembly of First Nations. Concerns included sovereignty claims referenced in United Nations Declaration on the Rights of Indigenous Peoples and intellectual property disputes involving institutions like World Intellectual Property Organization. Legal scholars from Harvard Law School and Yale Law School raised questions about benefit-sharing models exemplified by agreements like the Nagoya Protocol. Bioethicists associated with The Hastings Center and Nuffield Council on Bioethics critiqued consent frameworks used in research at Tufts University and Duke University.

Critics from organizations including Survival International, Rainforest Action Network, and the International Indian Treaty Council argued the project risked exploitation of indigenous peoples and could enable bioprospecting by corporations such as Monsanto and Novartis. Scholars like Paul Farmer and Eben Kirksey raised concerns about power asymmetries paralleling historical injustices linked to events like the Colonialism in Africa and controversies such as the Havasupai Tribe v. Arizona State University case. Debates played out in media outlets including Nature, Science, The Lancet, and the New York Times, producing policy responses from funders like the National Science Foundation and activist campaigns coordinated via International Indian Treaty Council and Cultural Survival.

Elements of the project informed subsequent efforts including the 1000 Genomes Project, the Human Origins dataset curated at the Max Planck Institute for Evolutionary Anthropology, the Human Heredity and Health in Africa (H3Africa) consortium, and regional studies led by Australian National University and University of Cape Town. Ethical frameworks developed influenced protocols adopted by the Global Alliance for Genomics and Health and data governance models at the European Genome-phenome Archive. The discourse shaped collaborations between universities such as University of British Columbia, policy bodies like the World Health Organization, and indigenous-led research exemplified by initiatives at Te Papa Tongarewa and Massey University.